WEBSITECHANGES

Website Changes

---

01/11/2011

Blocking Multiple Cell Signaling Pathways at Once: a Better Way to Treat Deadly Brain Tumors?

---

01/11/2011

A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.

---

01/11/2011

Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?

---

01/10/2011

Adverse events associated with the use of complementary and alternative medicine in children.

---

01/08/2011

Pseudoprogression following chemoradiotherapy for glioblastoma multiforme.

---

01/07/2011

Financial Challenges: Practical Suggestions For Brain Tumor Families

---

01/04/2011

Healthcare Innovators Announce Clinical Trials for Brain Tumor Vaccine

---

01/03/2011

Pharma Strategy Blog: Glioblastoma recurrence after VEGF therapy: lack of rebound vascularisation as a mode of escape

---

01/03/2011

Musella Foundation Online Support Group changes name!

---

12/29/2010

Functional Drug Screening Assay Reveals Potential Glioma Therapeutics.

---

12/29/2010

Rindopepimut,[CDX-110 vaccine] a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme.

---

12/28/2010

Epicept announces start of phase IIb trial with brain tumour treatment

---

12/28/2010

The paradoxical effect of bevacizumab in the therapy of malignant gliomas

---

12/23/2010

Electrical Device for Cancer Treatment Polarizes Audiences

---

12/23/2010

ImmunoCellular Therapeutics (IMUC): At the Forefront of Brain Tumor Treatment

---

12/23/2010

Peregrine Completes Treatment of Last Patient in Phase II Cotara(R) Brain Cancer Trial

---

12/22/2010

Updated survivor story for Rose - a 4 year gbm survivor - recently with a clean scan!

---

12/17/2010

virtualtrials.com is back up!

---

12/17/2010

Insight offers new angle of attack on variety of brain tumors

---

12/16/2010

IBTA December 2010 E-News

---

12/15/2010

Florida Brain Tumor Association Brain Tumor Conference

---

12/14/2010

Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With a-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma [Editor`s Note: This project was funded by the Musella Foundation]

---

12/07/2010

Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme

---

12/04/2010

New Drugs Target Recurrent Meningioma

---

12/02/2010

Device for Glioblastoma May Offer Advantage Over Chemo

---